Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells

D Reinhold, U Bank, F Bühling, U Lendeckel, J Faust, K Neubert, S Ansorge, D Reinhold, U Bank, F Bühling, U Lendeckel, J Faust, K Neubert, S Ansorge

Abstract

Various studies have shown that the membrane ectoenzyme dipeptidyl peptidase IV (DP IV; CD26), expressed on T, natural killer (NK) and B cells in the immune system, is involved in the regulation of DNA synthesis and cytokine production. We show that the specific DP IV inhibitors Lys[Z(NO2)]-thiazolidide, Lys[Z(NO2)]-piperidide, and Lys[Z(NO2)]-pyrrolidide inhibit DNA synthesis as well as production of interleukin-2 (IL-2), IL-10, IL-12, and interferon-gamma (IFN-gamma) of pokeweed mitogen (PWM)-stimulated purified T cells. Most importantly, these inhibitors induce a three- to fourfold increased secretion of latent transforming growth factor-beta 1 (TGF-beta 1) by PWM-stimulated peripheral blood mononuclear cells (PBMC) and T cells, as measured with a specific TGF-beta 1 enzyme-linked immunosorbent assay and in the Mv1Lu bioassay. As we could demonstrate previously, TGF-beta 1 exhibits the same inhibitory effects as DP IV inhibitors on DNA synthesis and cytokine production (Cytokine 1994, 6, 382-8; J Interferon Cytokine Res 1995, 15, 685-90). A neutralizing chicken anti-TGF-beta 1 antibody was capable of abolishing the DP IV inhibitor-induced suppression of DNA synthesis of PWM-stimulated PBMC and T cells. These data suggest that TGF-beta 1 might have key functions in the molecular action of DP IV/CD26 in regulation of DNA synthesis and cytokine production.

References

    1. Immunobiology. 1993 Aug;188(4-5):403-14
    1. J Interferon Cytokine Res. 1995 Aug;15(8):685-90
    1. Immunol Today. 1994 Apr;15(4):180-4
    1. Cytokine. 1994 Jul;6(4):382-8
    1. Nat Immun. 1994 Sep-Oct;13(5):270-9
    1. Eur J Immunol. 1995 Jan;25(1):295-7
    1. Immunobiology. 1994 Dec;192(1-2):121-36
    1. Immunol Lett. 1995 Feb;45(1-2):47-51
    1. J Biol Chem. 1984 Aug 10;259(15):9756-61
    1. Biochem J. 1984 Oct 1;223(1):255-8
    1. Biomed Biochim Acta. 1986;45(11-12):1523-8
    1. J Immunol. 1988 Apr 1;140(7):2312-6
    1. J Immunol. 1988 May 1;140(9):3026-32
    1. Scand J Immunol. 1989 Feb;29(2):127-32
    1. J Immunol. 1989 Dec 1;143(11):3430-9
    1. Cell Immunol. 1990 Mar;126(1):47-56
    1. J Immunol. 1990 Jun 1;144(11):4092-100
    1. J Immunol. 1990 Dec 15;145(12):3963-71
    1. J Clin Invest. 1991 Mar;87(3):1010-6
    1. Eur J Immunol. 1991 Apr;21(4):1085-8
    1. FASEB J. 1991 Aug;5(11):2582-5
    1. Biol Chem Hoppe Seyler. 1991 May;372(5):305-11
    1. Biomed Biochim Acta. 1991;50(4-6):799-807
    1. J Immunol Methods. 1993 Jan 14;158(1):17-25
    1. Crit Rev Biochem Mol Biol. 1993;28(1):31-81
    1. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4586-90
    1. FEBS Lett. 1993 Dec 20;336(1):61-4

Source: PubMed

3
구독하다